17-alpha-Hydroxyprogesterone
The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Clarithromycin.
Abemaciclib
The risk or severity of adverse effects can be increased when Clarithromycin is combined with Abemaciclib.
Abiraterone
The metabolism of Abiraterone can be decreased when combined with Clarithromycin.
Advertisement
Acenocoumarol
The metabolism of Acenocoumarol can be decreased when combined with Clarithromycin.
Acetaminophen
The metabolism of Acetaminophen can be decreased when combined with Clarithromycin.
Acetyl Sulfisoxazole
The metabolism of Clarithromycin can be decreased when combined with Acetyl sulfisoxazole.
Advertisement
Acetyldigitoxin
The serum concentration of Acetyldigitoxin can be increased when it is combined with Clarithromycin.
Ado-Trastuzumab Emtansine
The serum concentration of the active metabolites of Trastuzumab emtansine can be increased when Trastuzumab emtansine is used in combination with Clarithromycin.
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Clarithromycin.
Advertisement
Albendazole
The metabolism of Albendazole can be decreased when combined with Clarithromycin.
Albuterol
Salbutamol may increase the QTc-prolonging activities of Clarithromycin.
Alclometasone
The metabolism of Alclometasone can be decreased when combined with Clarithromycin.
Aldosterone
The serum concentration of Aldosterone can be increased when it is combined with Clarithromycin.
Alfentanil
The serum concentration of Alfentanil can be increased when it is combined with Clarithromycin.
Alfuzosin
The serum concentration of Alfuzosin can be increased when it is combined with Clarithromycin.
Aliskiren
The metabolism of Aliskiren can be decreased when combined with Clarithromycin.
Allylestrenol
The metabolism of Allylestrenol can be decreased when combined with Clarithromycin.
Almotriptan
The serum concentration of Almotriptan can be increased when it is combined with Clarithromycin.
Alogliptin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Alogliptin.
Alosetron
The serum concentration of Alosetron can be increased when it is combined with Clarithromycin.
alpha 1-Antitrypsin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Alpha-1-proteinase inhibitor.
Alpha 1-Proteinase Inhibitor, Human
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Alpha-1-proteinase inhibitor.
alpha-Tocopherol Acetate
The metabolism of alpha-Tocopherol acetate can be decreased when combined with Clarithromycin.
Alprazolam
The serum concentration of Alprazolam can be increased when it is combined with Clarithromycin.
Amantadine
Amantadine may increase the QTc-prolonging activities of Clarithromycin.
Ambrisentan
The metabolism of Ambrisentan can be decreased when combined with Clarithromycin.
Ambroxol
The metabolism of Ambroxol can be decreased when combined with Clarithromycin.
AMBROXOL ACEFYLLINATE
The metabolism of Ambroxol acefyllinate can be decreased when combined with Clarithromycin.
Ambroxol-Theophylline-7-Acetate
The metabolism of Ambroxol acefyllinate can be decreased when combined with Clarithromycin.
Amcinonide
The serum concentration of Amcinonide can be increased when it is combined with Clarithromycin.
Aminophylline
The metabolism of Aminophylline can be decreased when combined with Clarithromycin.
Aminopyrine
The metabolism of Aminophenazone can be decreased when combined with Clarithromycin.
Amiodarone
Clarithromycin may increase the QTc-prolonging activities of Amiodarone.
Amitriptyline
The metabolism of Amitriptyline can be decreased when combined with Clarithromycin.
Amlodipine
The metabolism of Amlodipine can be decreased when combined with Clarithromycin.
Amoxapine
Amoxapine may increase the QTc-prolonging activities of Clarithromycin.
Amprenavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Amprenavir.
Anagrelide
Clarithromycin may increase the QTc-prolonging activities of Anagrelide.
Androstenedione
The serum concentration of Androstenedione can be increased when it is combined with Clarithromycin.
Anhydrous Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.
Antipyrine
The metabolism of Antipyrine can be decreased when combined with Clarithromycin.
Antithrombin III
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Antithrombin III human.
Antithrombin III, Human
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Antithrombin III human.
Apalutamide
The serum concentration of Apalutamide can be increased when it is combined with Clarithromycin.
Apixaban
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Apixaban.
Apomorphine
Apomorphine may increase the QTc-prolonging activities of Clarithromycin.
Apremilast
The metabolism of Apremilast can be decreased when combined with Clarithromycin.
Aprepitant
The serum concentration of Clarithromycin can be increased when it is combined with Aprepitant.
Aprotinin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Aprotinin.
Arformoterol
Arformoterol may increase the QTc-prolonging activities of Clarithromycin.
Argatroban
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Argatroban.
Argatroban Anhydrous
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Argatroban.
Aripiprazole
The serum concentration of Aripiprazole can be increased when it is combined with Clarithromycin.
Armodafinil
The metabolism of Clarithromycin can be decreased when combined with Armodafinil.
Arsenic Trioxide
Clarithromycin may increase the QTc-prolonging activities of Arsenic trioxide.
Artemether
Clarithromycin may increase the QTc-prolonging activities of Artemether.
Asenapine
Clarithromycin may increase the QTc-prolonging activities of Asenapine.
Astemizole
The serum concentration of Astemizole can be increased when it is combined with Clarithromycin.
Asunaprevir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Asunaprevir.
Atazanavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Atazanavir.
Atomoxetine
The metabolism of Clarithromycin can be decreased when combined with Atomoxetine.
Atorvastatin
The serum concentration of Atorvastatin can be increased when it is combined with Clarithromycin.
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Clarithromycin.
Avatrombopag
The metabolism of Avatrombopag can be decreased when combined with Clarithromycin.
Axitinib
The serum concentration of Axitinib can be increased when it is combined with Clarithromycin.
Azelastine
The metabolism of Azelastine can be decreased when combined with Clarithromycin.
Azithromycin
The metabolism of Azithromycin can be decreased when combined with Clarithromycin.
Baricitinib
The metabolism of Baricitinib can be decreased when combined with Clarithromycin.
BCG Vaccine
The therapeutic efficacy of BCG vaccine can be decreased when used in combination with Clarithromycin.
Beclomethasone Dipropionate
The serum concentration of Beclomethasone dipropionate can be increased when it is combined with Clarithromycin.
Bedaquiline
The serum concentration of Bedaquiline can be increased when it is combined with Clarithromycin.
Benazepril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Benazepril.
Benzphetamine
The metabolism of Benzphetamine can be decreased when combined with Clarithromycin.
Benzyl Alcohol
The metabolism of Benzyl alcohol can be decreased when combined with Clarithromycin.
Betamethasone
The serum concentration of Betamethasone can be increased when it is combined with Clarithromycin.
Bexarotene
The metabolism of Bexarotene can be decreased when combined with Clarithromycin.
Bezafibrate
The metabolism of Bezafibrate can be decreased when combined with Clarithromycin.
Bicalutamide
The metabolism of Bicalutamide can be decreased when combined with Clarithromycin.
Bictegravir
The metabolism of Bictegravir can be decreased when combined with Clarithromycin.
Bioallethrin
The metabolism of Bioallethrin can be decreased when combined with Clarithromycin.
Bisoprolol
The metabolism of Bisoprolol can be decreased when combined with Clarithromycin.
Bivalirudin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Bivalirudin.
Boceprevir
The serum concentration of Boceprevir can be increased when it is combined with Clarithromycin.
Bortezomib
The serum concentration of Bortezomib can be increased when it is combined with Clarithromycin.
Bosentan
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Bosentan.
Bosentan Anhydrous
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Bosentan.
Bosutinib
The serum concentration of Bosutinib can be increased when it is combined with Clarithromycin.
Bosutinib monohydrate
The serum concentration of Bosutinib can be increased when it is combined with Clarithromycin.
Brentuximab Vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Clarithromycin.
Brexpiprazole
The serum concentration of Brexpiprazole can be increased when it is combined with Clarithromycin.
Brigatinib
The serum concentration of Brigatinib can be increased when it is combined with Clarithromycin.
Brinzolamide
The serum concentration of Brinzolamide can be increased when it is combined with Clarithromycin.
Brivaracetam
The metabolism of Brivaracetam can be decreased when combined with Clarithromycin.
Bromazepam
The metabolism of Bromazepam can be decreased when combined with Clarithromycin.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Clarithromycin.
Brompheniramine
The metabolism of Brompheniramine can be decreased when combined with Clarithromycin.
Budesonide
The serum concentration of Budesonide can be increased when it is combined with Clarithromycin.
Bupivacaine
The metabolism of Bupivacaine can be decreased when combined with Clarithromycin.
Buprenorphine
The metabolism of Buprenorphine can be decreased when combined with Clarithromycin.
Bupropion
The metabolism of Bupropion can be decreased when combined with Clarithromycin.
Buserelin
Buserelin may increase the QTc-prolonging activities of Clarithromycin.
Buspirone
The metabolism of Buspirone can be decreased when combined with Clarithromycin.
Busulfan
The metabolism of Busulfan can be decreased when combined with Clarithromycin.
Cabazitaxel
The serum concentration of Cabazitaxel can be increased when it is combined with Clarithromycin.
Cabergoline
The serum concentration of Cabergoline can be increased when it is combined with Clarithromycin.
Cabozantinib
The serum concentration of Cabozantinib can be increased when it is combined with Clarithromycin.
Caffeine
The metabolism of Caffeine can be decreased when combined with Clarithromycin.
Calcitriol
The metabolism of Calcitriol can be decreased when combined with Clarithromycin.
Canagliflozin
The metabolism of Canagliflozin can be decreased when combined with Clarithromycin.
Canagliflozin Anhydrous
The metabolism of Canagliflozin can be decreased when combined with Clarithromycin.
Cannabidiol
The metabolism of Cannabidiol can be decreased when combined with Clarithromycin.
Cannavis sativa susp. indica top extract
The metabolism of Medical Cannabis can be decreased when combined with Clarithromycin.
Captopril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Captopril.
Carbamazepine
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine.
Carbinoxamine
The metabolism of Carbinoxamine can be decreased when combined with Clarithromycin.
Cariprazine
The metabolism of Cariprazine can be decreased when combined with Clarithromycin.
Carvedilol
The metabolism of Carvedilol can be decreased when combined with Clarithromycin.
Celecoxib
The metabolism of Celecoxib can be decreased when combined with Clarithromycin.
Celiprolol
The metabolism of Celiprolol can be decreased when combined with Clarithromycin.
Cephalexin
The metabolism of Cephalexin can be decreased when combined with Clarithromycin.
CEPHALEXIN ANHYDROUS
The metabolism of Cephalexin can be decreased when combined with Clarithromycin.
Ceritinib
The serum concentration of Ceritinib can be increased when it is combined with Clarithromycin.
Cerivastatin
The serum concentration of Cerivastatin can be increased when it is combined with Clarithromycin.
Cevimeline
The metabolism of Cevimeline can be decreased when combined with Clarithromycin.
Chenodeoxycholate
The metabolism of Chenodeoxycholic acid can be decreased when combined with Clarithromycin.
Chenodeoxycholic Acid
The metabolism of Chenodeoxycholic acid can be decreased when combined with Clarithromycin.
Chloramphenicol
The metabolism of Clarithromycin can be decreased when combined with Chloramphenicol.
Chlordiazepoxide
The metabolism of Chlordiazepoxide can be decreased when combined with Clarithromycin.
Chlormethiazole
The metabolism of clomethiazole can be decreased when combined with Clarithromycin.
Chloroquine
The metabolism of Chloroquine can be decreased when combined with Clarithromycin.
Chlorpheniramine
The metabolism of Chlorphenamine can be decreased when combined with Clarithromycin.
CHLORPHENIRAMINE POLISTIREX
The metabolism of Chlorphenamine can be decreased when combined with Clarithromycin.
Chlorpromazine
The metabolism of Chlorpromazine can be decreased when combined with Clarithromycin.
Chlorzoxazone
The metabolism of Chlorzoxazone can be decreased when combined with Clarithromycin.
Cholecalciferol
The metabolism of Cholecalciferol can be decreased when combined with Clarithromycin.
Ciclesonide
The metabolism of Ciclesonide can be decreased when combined with Clarithromycin.
Cilastatin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Cilastatin.
Cilazapril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Cilazapril.
Cilostazol
The serum concentration of Cilostazol can be increased when it is combined with Clarithromycin.
Cimetidine
The metabolism of Clarithromycin can be decreased when combined with Cimetidine.
Cinacalcet
The metabolism of Cinacalcet can be decreased when combined with Clarithromycin.
Ciprofloxacin
Ciprofloxacin may increase the QTc-prolonging activities of Clarithromycin.
Cisapride
The serum concentration of Cisapride can be increased when it is combined with Clarithromycin.
Citalopram
Clarithromycin may increase the QTc-prolonging activities of Citalopram.
Clemastine
The metabolism of Clarithromycin can be decreased when combined with Clemastine.
Clindamycin
The metabolism of Clindamycin can be decreased when combined with Clarithromycin.
Clobazam
The metabolism of Clobazam can be decreased when combined with Clarithromycin.
Clobetasol
The serum concentration of Clobetasol can be increased when it is combined with Clarithromycin.
Clobetasol Propionate
The serum concentration of Clobetasol propionate can be increased when it is combined with Clarithromycin.
Clobetasone
The serum concentration of Clobetasone can be increased when it is combined with Clarithromycin.
Clocortolone
The serum concentration of Clocortolone can be increased when it is combined with Clarithromycin.
Clofazimine
The metabolism of Clofazimine can be decreased when combined with Clarithromycin.
Clofezone
The metabolism of Rabeprazole can be decreased when combined with Clarithromycin.
Clofibrate
The metabolism of Clofibrate can be decreased when combined with Clarithromycin.
Clomipramine
The metabolism of Clomipramine can be decreased when combined with Clarithromycin.
Clonazepam
The metabolism of Clonazepam can be decreased when combined with Clarithromycin.
Clonidine
The metabolism of Clonidine can be decreased when combined with Clarithromycin.
Clopidogrel
The metabolism of Clopidogrel can be decreased when combined with Clarithromycin.
Clorazepate
The metabolism of Clorazepate can be decreased when combined with Clarithromycin.
CLORAZEPIC ACID
The metabolism of Clorazepate can be decreased when combined with Clarithromycin.
Clotiazepam
The metabolism of Clotiazepam can be decreased when combined with Clarithromycin.
Clotrimazole
The metabolism of Clarithromycin can be decreased when combined with Clotrimazole.
Clozapine
The metabolism of Clozapine can be decreased when combined with Clarithromycin.
Cobicistat
The serum concentration of Cobicistat can be increased when it is combined with Clarithromycin.
Cobimetinib
The serum concentration of Cobimetinib can be increased when it is combined with Clarithromycin.
Cocaine
The metabolism of Cocaine can be decreased when combined with Clarithromycin.
Codeine
The metabolism of Codeine can be decreased when combined with Clarithromycin.
Codeine Anhydrous
The metabolism of Codeine can be decreased when combined with Clarithromycin.
CODEINE POLISTIREX
The metabolism of Codeine can be decreased when combined with Clarithromycin.
Colchicine
The serum concentration of Colchicine can be increased when it is combined with Clarithromycin.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Clarithromycin.
Copanlisib
The metabolism of Copanlisib can be decreased when combined with Clarithromycin.
Cortisone Acetate
The metabolism of Cortisone acetate can be decreased when combined with Clarithromycin.
Crizotinib
The serum concentration of Crizotinib can be increased when it is combined with Clarithromycin.
Curcumin
The metabolism of Clarithromycin can be decreased when combined with Curcumin.
Cyclobenzaprine
The metabolism of Cyclobenzaprine can be decreased when combined with Clarithromycin.
Cyclophosphamide
The metabolism of Cyclophosphamide can be decreased when combined with Clarithromycin.
Cyclophosphamide Anhydrous
The metabolism of Cyclophosphamide can be decreased when combined with Clarithromycin.
Cyclosporine
The metabolism of Cyclosporine can be decreased when combined with Clarithromycin.
Cytarabine
The metabolism of Cytarabine can be decreased when combined with Clarithromycin.
Dabigatran Etexilate
The serum concentration of Dabigatran etexilate can be increased when it is combined with Clarithromycin.
Dabrafenib
The serum concentration of Clarithromycin can be decreased when it is combined with Dabrafenib.
Daclatasvir
The serum concentration of Daclatasvir can be increased when it is combined with Clarithromycin.
Dantrolene
The metabolism of Dantrolene can be decreased when combined with Clarithromycin.
Dapagliflozin
The metabolism of Dapagliflozin can be decreased when combined with Clarithromycin.
Dapsone
The metabolism of Dapsone can be decreased when combined with Clarithromycin.
Darifenacin
The metabolism of Darifenacin can be decreased when combined with Clarithromycin.
Darunavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Darunavir.
Dasabuvir
The metabolism of Dasabuvir can be decreased when combined with Clarithromycin.
Dasatinib
The serum concentration of Dasatinib can be increased when it is combined with Clarithromycin.
Dasatinib Anhydrous
The serum concentration of Dasatinib can be increased when it is combined with Clarithromycin.
Daunorubicin
The metabolism of Daunorubicin can be decreased when combined with Clarithromycin.
Deferasirox
The serum concentration of Clarithromycin can be decreased when it is combined with Deferasirox.
Deflazacort
The metabolism of Deflazacort can be decreased when combined with Clarithromycin.
Degarelix
Degarelix may increase the QTc-prolonging activities of Clarithromycin.
Delavirdine
The metabolism of Delavirdine can be decreased when combined with Clarithromycin.
Desflurane
Desflurane may increase the QTc-prolonging activities of Clarithromycin.
Desipramine
Desipramine may increase the QTc-prolonging activities of Clarithromycin.
Deslanoside
The serum concentration of Deslanoside can be increased when it is combined with Clarithromycin.
Desonide
The serum concentration of Desonide can be increased when it is combined with Clarithromycin.
Desoximetasone
The serum concentration of Desoximetasone can be increased when it is combined with Clarithromycin.
Desoxycorticosterone acetate
The serum concentration of Desoxycorticosterone acetate can be increased when it is combined with Clarithromycin.
Desoxycorticosterone Pivalate
The serum concentration of Desoxycorticosterone Pivalate can be increased when it is combined with Clarithromycin.
Desvenlafaxine
The metabolism of Desvenlafaxine can be decreased when combined with Clarithromycin.
Deutetrabenazine
Clarithromycin may increase the QTc-prolonging activities of Deutetrabenazine.
Dexamethasone
The metabolism of Dexamethasone can be decreased when combined with Clarithromycin.
Dexchlorpheniramine maleate
The metabolism of Dexchlorpheniramine maleate can be decreased when combined with Clarithromycin.
Dexlansoprazole
The metabolism of Dexlansoprazole can be decreased when combined with Clarithromycin.
Dextromethorphan
The metabolism of Dextromethorphan can be decreased when combined with Clarithromycin.
Diazepam
The metabolism of Diazepam can be decreased when combined with Clarithromycin.
Diclofenac
The metabolism of Diclofenac can be decreased when combined with Clarithromycin.
Dicumarol
The serum concentration of Dicoumarol can be increased when it is combined with Clarithromycin.
Dienogest
The serum concentration of Dienogest can be increased when it is combined with Clarithromycin.
Diflorasone
The serum concentration of Diflorasone can be increased when it is combined with Clarithromycin.
Diflucortolone
The serum concentration of Difluocortolone can be increased when it is combined with Clarithromycin.
Difluprednate
The serum concentration of Difluprednate can be increased when it is combined with Clarithromycin.
Digitoxin
The metabolism of Digitoxin can be decreased when combined with Clarithromycin.
Digoxin
The metabolism of Digoxin can be decreased when combined with Clarithromycin.
Dihydro-alpha-ergocryptine
The metabolism of Dihydro-alpha-ergocryptine can be decreased when combined with Clarithromycin.
Dihydrocodeine
The metabolism of Dihydrocodeine can be decreased when combined with Clarithromycin.
Dihydroergocornine
The risk or severity of adverse effects can be increased when Dihydroergocornine is combined with Clarithromycin.
Dihydroergocristine
The risk or severity of adverse effects can be increased when Dihydroergocristine is combined with Clarithromycin.
Dihydroergocryptine
The metabolism of Dihydro-alpha-ergocryptine can be decreased when combined with Clarithromycin.
Dihydroergotamine
The serum concentration of Dihydroergotamine can be increased when it is combined with Clarithromycin.
Diltiazem
The metabolism of Diltiazem can be decreased when combined with Clarithromycin.
Diphenhydramine
Diphenhydramine may increase the QTc-prolonging activities of Clarithromycin.
Disopyramide
Clarithromycin may increase the QTc-prolonging activities of Disopyramide.
Disulfiram
The metabolism of Disulfiram can be decreased when combined with Clarithromycin.
Dl-Alpha Tocopheryl Acetate
The metabolism of alpha-Tocopherol acetate can be decreased when combined with Clarithromycin.
Docetaxel
The metabolism of Docetaxel can be decreased when combined with Clarithromycin.
DOCETAXEL ANHYDROUS
The metabolism of Docetaxel can be decreased when combined with Clarithromycin.
Dofetilide
The serum concentration of Dofetilide can be increased when it is combined with Clarithromycin.
Dolasetron
The metabolism of Dolasetron can be decreased when combined with Clarithromycin.
Domperidone
The serum concentration of Domperidone can be increased when it is combined with Clarithromycin.
Donepezil
The metabolism of Donepezil can be decreased when combined with Clarithromycin.
Dorzolamide
The metabolism of Dorzolamide can be decreased when combined with Clarithromycin.
Doxepin
The metabolism of Doxepin can be decreased when combined with Clarithromycin.
Doxorubicin
The serum concentration of Doxorubicin can be increased when it is combined with Clarithromycin.
Doxorubicin Hydrochloride
The serum concentration of Doxorubicin can be increased when it is combined with Clarithromycin.
Doxycycline
The metabolism of Clarithromycin can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Clarithromycin can be decreased when combined with Doxycycline.
Dronedarone
The serum concentration of Dronedarone can be increased when it is combined with Clarithromycin.
Droperidol
Droperidol may increase the QTc-prolonging activities of Clarithromycin.
Drospirenone
The serum concentration of Drospirenone can be increased when it is combined with Clarithromycin.
Dutasteride
The serum concentration of Dutasteride can be increased when it is combined with Clarithromycin.
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Clarithromycin.
Efavirenz
The serum concentration of Clarithromycin can be decreased when it is combined with Efavirenz.
Elbasvir
The metabolism of Elbasvir can be decreased when combined with Clarithromycin.
Eletriptan
The serum concentration of Eletriptan can be increased when it is combined with Clarithromycin.
Eliglustat
The serum concentration of Eliglustat can be increased when it is combined with Clarithromycin.
Elvitegravir
The metabolism of Elvitegravir can be decreased when combined with Clarithromycin.
Enalapril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Enalapril.
Enalaprilat
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Enalaprilat.
Enalaprilat Anhydrous
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Enalaprilat.
Enasidenib
The metabolism of Enasidenib can be decreased when combined with Clarithromycin.
Enzalutamide
The serum concentration of Clarithromycin can be decreased when it is combined with Enzalutamide.
Epinastine
The metabolism of Epinastine can be decreased when combined with Clarithromycin.
Eplerenone
The serum concentration of Eplerenone can be increased when it is combined with Clarithromycin.
Ergocalciferol
The metabolism of Ergocalciferol can be decreased when combined with Clarithromycin.
ergoloid mesylates, USP
The metabolism of Ergoloid mesylate can be decreased when combined with Clarithromycin.
Ergonovine
The risk or severity of adverse effects can be increased when Ergonovine is combined with Clarithromycin.
Ergotamine
The serum concentration of Ergotamine can be increased when it is combined with Clarithromycin.
Eribulin
Eribulin may increase the QTc-prolonging activities of Clarithromycin.
Erlotinib
The serum concentration of Erlotinib can be increased when it is combined with Clarithromycin.
Erythromycin
The metabolism of Erythromycin can be decreased when combined with Clarithromycin.
Escitalopram
Clarithromycin may increase the QTc-prolonging activities of Escitalopram.
Eslicarbazepine Acetate
The metabolism of Clarithromycin can be decreased when combined with Eslicarbazepine acetate.
Esomeprazole
The metabolism of Esomeprazole can be decreased when combined with Clarithromycin.
Estazolam
The serum concentration of Estazolam can be increased when it is combined with Clarithromycin.
Estradiol
The metabolism of Estradiol can be decreased when combined with Clarithromycin.
Estradiol 3-Benzoate
The metabolism of Estradiol benzoate can be decreased when combined with Clarithromycin.
Estradiol acetate
The metabolism of Estradiol acetate can be decreased when combined with Clarithromycin.
Estradiol Cypionate
The metabolism of Estradiol cypionate can be decreased when combined with Clarithromycin.
Estradiol Valerate
The metabolism of Estradiol valerate can be decreased when combined with Clarithromycin.
Estramustine
The metabolism of Estramustine can be decreased when combined with Clarithromycin.
Estrogens, Conjugated (USP)
The metabolism of Conjugated estrogens can be decreased when combined with Clarithromycin.
Estrogens, Esterified (USP)
The metabolism of Estrogens, esterified can be decreased when combined with Clarithromycin.
Estrone
The metabolism of Estrone can be decreased when combined with Clarithromycin.
Eszopiclone
The metabolism of Eszopiclone can be decreased when combined with Clarithromycin.
Ethanol
The metabolism of Ethanol can be decreased when combined with Clarithromycin.
Ethinyl Estradiol
The metabolism of Ethinyl Estradiol can be decreased when combined with Clarithromycin.
Ethosuximide
The metabolism of Ethosuximide can be decreased when combined with Clarithromycin.
Ethylmorphine
The metabolism of Ethylmorphine can be decreased when combined with Clarithromycin.
Etonogestrel
The metabolism of Etonogestrel can be decreased when combined with Clarithromycin.
Etoposide
The metabolism of Etoposide can be decreased when combined with Clarithromycin.
Etoricoxib
The metabolism of Etoricoxib can be decreased when combined with Clarithromycin.
Etravirine
The metabolism of Etravirine can be decreased when combined with Clarithromycin.
Everolimus
The serum concentration of Everolimus can be increased when it is combined with Clarithromycin.
Exemestane
The metabolism of Exemestane can be decreased when combined with Clarithromycin.
Ezogabine
Ezogabine may increase the QTc-prolonging activities of Clarithromycin.
Famciclovir
The metabolism of Famciclovir can be decreased when combined with Clarithromycin.
Famotidine
Famotidine may increase the QTc-prolonging activities of Clarithromycin.
Felbamate
The metabolism of Felbamate can be decreased when combined with Clarithromycin.
Felodipine
The metabolism of Felodipine can be decreased when combined with Clarithromycin.
Fenofibrate
The metabolism of Fenofibrate can be decreased when combined with Clarithromycin.
Fentanyl
The serum concentration of Fentanyl can be increased when it is combined with Clarithromycin.
Fesoterodine
The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Clarithromycin.
Fibrinolysis Inhibitor
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Aprotinin.
Finasteride
The metabolism of Finasteride can be decreased when combined with Clarithromycin.
Fingolimod
The metabolism of Fingolimod can be decreased when combined with Clarithromycin.
Flecainide
Flecainide may increase the QTc-prolonging activities of Clarithromycin.
Flibanserin
The serum concentration of Flibanserin can be increased when it is combined with Clarithromycin.
Fluconazole
The metabolism of Clarithromycin can be decreased when combined with Fluconazole.
Fludrocortisone
The serum concentration of Fludrocortisone can be increased when it is combined with Clarithromycin.
Fluindione
The serum concentration of Fluindione can be increased when it is combined with Clarithromycin.
Flumethasone
The serum concentration of Flumethasone can be increased when it is combined with Clarithromycin.
Flunisolide
The metabolism of Flunisolide can be decreased when combined with Clarithromycin.
Flunisolide Anhydrous (obsolete)
The metabolism of Flunisolide can be decreased when combined with Clarithromycin.
Flunitrazepam
The metabolism of Flunitrazepam can be decreased when combined with Clarithromycin.
Fluocinolone Acetonide
The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Clarithromycin.
Fluocinonide
The serum concentration of Fluocinonide can be increased when it is combined with Clarithromycin.
Fluocortolone
The serum concentration of Fluocortolone can be increased when it is combined with Clarithromycin.
Fluorometholone
The metabolism of Fluorometholone can be decreased when combined with Clarithromycin.
Fluoxetine
Clarithromycin may increase the QTc-prolonging activities of Fluoxetine.
Flupenthixol
Clarithromycin may increase the QTc-prolonging activities of Flupentixol.
FLUPREDNIDENE
The serum concentration of Fluprednidene can be increased when it is combined with Clarithromycin.
Fluprednisolone
The serum concentration of Fluprednisolone can be increased when it is combined with Clarithromycin.
Flurandrenolide
The serum concentration of Flurandrenolide can be increased when it is combined with Clarithromycin.
Flurazepam
The metabolism of Flurazepam can be decreased when combined with Clarithromycin.
Flutamide
The metabolism of Flutamide can be decreased when combined with Clarithromycin.
Fluticasone
The serum concentration of Fluticasone can be increased when it is combined with Clarithromycin.
Fluticasone Furoate
The metabolism of Fluticasone furoate can be decreased when combined with Clarithromycin.
Fluticasone propionate
The serum concentration of Fluticasone propionate can be increased when it is combined with Clarithromycin.
Fluvastatin
The serum concentration of Fluvastatin can be increased when it is combined with Clarithromycin.
Fluvoxamine
The metabolism of Clarithromycin can be decreased when combined with Fluvoxamine.
Formestane
The serum concentration of Formestane can be increased when it is combined with Clarithromycin.
Formoterol
Formoterol may increase the QTc-prolonging activities of Clarithromycin.
Fosamprenavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Fosamprenavir.
Fosaprepitant
The serum concentration of Clarithromycin can be increased when it is combined with Fosaprepitant.
Foscarnet
Foscarnet may increase the QTc-prolonging activities of Clarithromycin.
Fosinopril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Fosinopril.
Fosnetupitant
The metabolism of Fosnetupitant can be decreased when combined with Clarithromycin.
Fosphenytoin
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Fosphenytoin.
Fostamatinib
The metabolism of Fostamatinib can be decreased when combined with Clarithromycin.
Fulvestrant
The metabolism of Fulvestrant can be decreased when combined with Clarithromycin.
Fusidate
The serum concentration of Clarithromycin can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Clarithromycin can be increased when it is combined with Fusidic Acid.
Gadobenate
Gadobenic acid may increase the QTc-prolonging activities of Clarithromycin.
Galantamine
The metabolism of Galantamine can be decreased when combined with Clarithromycin.
Gefitinib
The metabolism of Gefitinib can be decreased when combined with Clarithromycin.
Gemfibrozil
The metabolism of Gemfibrozil can be decreased when combined with Clarithromycin.
Gemifloxacin
Gemifloxacin may increase the QTc-prolonging activities of Clarithromycin.
Gemifloxacin Mesylate
Gemifloxacin may increase the QTc-prolonging activities of Clarithromycin.
Glipizide
The serum concentration of Glipizide can be increased when it is combined with Clarithromycin.
Glyburide
The serum concentration of Glyburide can be increased when it is combined with Clarithromycin.
Goserelin
Goserelin may increase the QTc-prolonging activities of Clarithromycin.
Granisetron
The metabolism of Granisetron can be decreased when combined with Clarithromycin.
Grazoprevir
The metabolism of Grazoprevir can be decreased when combined with Clarithromycin.
Grazoprevir anhydrous
The metabolism of Grazoprevir can be decreased when combined with Clarithromycin.
Grepafloxacin
The metabolism of Grepafloxacin can be decreased when combined with Clarithromycin.
Guanfacine
The serum concentration of Guanfacine can be increased when it is combined with Clarithromycin.
Halcinonide
The serum concentration of Halcinonide can be increased when it is combined with Clarithromycin.
Halobetasol
The serum concentration of Ulobetasol can be increased when it is combined with Clarithromycin.
Halofantrine
The serum concentration of Halofantrine can be increased when it is combined with Clarithromycin.
Haloperidol
The metabolism of Haloperidol can be decreased when combined with Clarithromycin.
Halothane
The metabolism of Halothane can be decreased when combined with Clarithromycin.
Hexobarbital
The metabolism of Hexobarbital can be decreased when combined with Clarithromycin.
Histamine
The metabolism of Histamine can be decreased when combined with Clarithromycin.
Histrelin
Histrelin may increase the QTc-prolonging activities of Clarithromycin.
Hydrocodone
The serum concentration of Hydrocodone can be increased when it is combined with Clarithromycin.
HYDROCODONE POLISTIREX
The serum concentration of Hydrocodone can be increased when it is combined with Clarithromycin.
Hydrocortisone
The metabolism of Hydrocortisone can be decreased when combined with Clarithromycin.
Hydromorphone
The metabolism of Hydromorphone can be decreased when combined with Clarithromycin.
hydroxyprogesterone caproate (USP)
The metabolism of Hydroxyprogesterone caproate can be decreased when combined with Clarithromycin.
Hydroxyzine
Hydroxyzine may increase the QTc-prolonging activities of Clarithromycin.
Hypoxis hemerocallidea root extract
The serum concentration of Clarithromycin can be decreased when it is combined with St. John's Wort.
Ibandronate
Ibandronate may increase the QTc-prolonging activities of Clarithromycin.
Ibandronic Acid
Ibandronate may increase the QTc-prolonging activities of Clarithromycin.
Ibrutinib
The serum concentration of Ibrutinib can be increased when it is combined with Clarithromycin.
Ibutilide
Clarithromycin may increase the QTc-prolonging activities of Ibutilide.
Idelalisib
The serum concentration of Idelalisib can be increased when it is combined with Clarithromycin.
Ifosfamide
The serum concentration of the active metabolites of Ifosfamide can be reduced when Ifosfamide is used in combination with Clarithromycin resulting in a loss in efficacy.
Iloperidone
The serum concentration of the active metabolites of Iloperidone can be increased when Iloperidone is used in combination with Clarithromycin.
Imatinib
The serum concentration of Imatinib can be increased when it is combined with Clarithromycin.
Imidapril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Imidapril.
Imipramine
The metabolism of Imipramine can be decreased when combined with Clarithromycin.
Imiquimod
The metabolism of Imiquimod can be decreased when combined with Clarithromycin.
Indacaterol
The metabolism of Indacaterol can be decreased when combined with Clarithromycin.
Indapamide
The metabolism of Indapamide can be decreased when combined with Clarithromycin.
Indinavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Indinavir.
INDINAVIR ANHYDROUS
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Indinavir.
Ipecac
The metabolism of Ipecac can be decreased when combined with Clarithromycin.
Ipratropium
The metabolism of Ipratropium bromide can be decreased when combined with Clarithromycin.
Ipratropium cation
The metabolism of Ipratropium bromide can be decreased when combined with Clarithromycin.
Irinotecan
The serum concentration of Irinotecan can be increased when it is combined with Clarithromycin.
Isavuconazole
The serum concentration of Isavuconazole can be increased when it is combined with Clarithromycin.
Isavuconazonium
The serum concentration of the active metabolites of Isavuconazonium can be increased when Isavuconazonium is used in combination with Clarithromycin.
Isoflurane
Isoflurane may increase the QTc-prolonging activities of Clarithromycin.
Isoflurophate
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Isoflurophate.
Isoniazid
The metabolism of Clarithromycin can be decreased when combined with Isoniazid.
Isosorbide Dinitrate
The metabolism of Isosorbide Dinitrate can be decreased when combined with Clarithromycin.
Isosorbide Mononitrate
The metabolism of Isosorbide Mononitrate can be decreased when combined with Clarithromycin.
Isradipine
The metabolism of Isradipine can be decreased when combined with Clarithromycin.
Itraconazole
The metabolism of Clarithromycin can be decreased when combined with Itraconazole.
Ivabradine
The serum concentration of Ivabradine can be increased when it is combined with Clarithromycin.
Ivacaftor
The serum concentration of Ivacaftor can be increased when it is combined with Clarithromycin.
Ivermectin
The metabolism of Ivermectin can be decreased when combined with Clarithromycin.
Ixabepilone
The serum concentration of Ixabepilone can be increased when it is combined with Clarithromycin.
Ixazomib
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Ixazomib.
Ketamine
The metabolism of Ketamine can be decreased when combined with Clarithromycin.
Ketazolam
The metabolism of Ketazolam can be decreased when combined with Clarithromycin.
Ketoconazole
The metabolism of Clarithromycin can be decreased when combined with Ketoconazole.
Lacidipine
The serum concentration of Lacidipine can be increased when it is combined with Clarithromycin.
Lacosamide
The serum concentration of Lacosamide can be increased when it is combined with Clarithromycin.
Lansoprazole
The metabolism of Lansoprazole can be decreased when combined with Clarithromycin.
Lapatinib
The serum concentration of Lapatinib can be increased when it is combined with Clarithromycin.
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Clarithromycin.
Lenvatinib
The metabolism of Lenvatinib can be decreased when combined with Clarithromycin.
Lenvatinib Mesylate
The metabolism of Lenvatinib can be decreased when combined with Clarithromycin.
Lepirudin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Lepirudin.
Lercanidipine
The serum concentration of Lercanidipine can be increased when it is combined with Clarithromycin.
Letrozole
The metabolism of Letrozole can be decreased when combined with Clarithromycin.
Leuprolide
Leuprolide may increase the QTc-prolonging activities of Clarithromycin.
Levobupivacaine
The serum concentration of Levobupivacaine can be increased when it is combined with Clarithromycin.
Levocetirizine
The metabolism of Levocetirizine can be decreased when combined with Clarithromycin.
Levofloxacin
Levofloxacin may increase the QTc-prolonging activities of Clarithromycin.
Levofloxacin Anhydrous
Levofloxacin may increase the QTc-prolonging activities of Clarithromycin.
Levomethadyl
The metabolism of Levomethadyl Acetate can be decreased when combined with Clarithromycin.
Levomilnacipran
The serum concentration of Levomilnacipran can be increased when it is combined with Clarithromycin.
Levonorgestrel
The metabolism of Levonorgestrel can be decreased when combined with Clarithromycin.
Levothyroxine
The metabolism of Levothyroxine can be decreased when combined with Clarithromycin.
Lidocaine
The metabolism of Lidocaine can be decreased when combined with Clarithromycin.
Linagliptin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Linagliptin.
Lisinopril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Lisinopril.
Lisinopril Anhydrous
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Lisinopril.
Lisuride
The risk or severity of adverse effects can be increased when Lisuride is combined with Clarithromycin.
Lithium
Lithium may increase the QTc-prolonging activities of Clarithromycin.
Lithium Cation
Lithium may increase the QTc-prolonging activities of Clarithromycin.
Lomitapide
The serum concentration of Lomitapide can be increased when it is combined with Clarithromycin.
Loperamide
The metabolism of Loperamide can be decreased when combined with Clarithromycin.
Lopinavir
Clarithromycin may increase the QTc-prolonging activities of Lopinavir.
Loratadine
The metabolism of Loratadine can be decreased when combined with Clarithromycin.
Lorcaserin
The metabolism of Lorcaserin can be decreased when combined with Clarithromycin.
Losartan
The metabolism of Losartan can be decreased when combined with Clarithromycin.
Loteprednol
The serum concentration of Loteprednol can be increased when it is combined with Clarithromycin.
Lovastatin
The serum concentration of Lovastatin can be increased when it is combined with Clarithromycin.
Luliconazole
The serum concentration of Clarithromycin can be increased when it is combined with Luliconazole.
Lumacaftor
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Lumacaftor.
Lumefantrine
The serum concentration of Lumefantrine can be increased when it is combined with Clarithromycin.
Lurasidone
The serum concentration of Lurasidone can be increased when it is combined with Clarithromycin.
Macimorelin
Clarithromycin may increase the QTc-prolonging activities of Macimorelin.
Macitentan
The serum concentration of Macitentan can be increased when it is combined with Clarithromycin.
Maprotiline
Maprotiline may increase the QTc-prolonging activities of Clarithromycin.
Maraviroc
The serum concentration of Maraviroc can be increased when it is combined with Clarithromycin.
Mebendazole
The metabolism of Mebendazole can be decreased when combined with Clarithromycin.
Medroxyprogesterone Acetate
The serum concentration of Medroxyprogesterone acetate can be increased when it is combined with Clarithromycin.
Medrysone
The serum concentration of Medrysone can be increased when it is combined with Clarithromycin.
Mefloquine
The metabolism of Mefloquine can be decreased when combined with Clarithromycin.
Meloxicam
The metabolism of Meloxicam can be decreased when combined with Clarithromycin.
Meperidine
The metabolism of Pethidine can be decreased when combined with Clarithromycin.
Mepirodipine
The serum concentration of Barnidipine can be increased when it is combined with Clarithromycin.
Metergoline
The risk or severity of adverse effects can be increased when Metergoline is combined with Clarithromycin.
Methadone
The metabolism of Methadone can be decreased when combined with Clarithromycin.
Methaqualone
The metabolism of Methaqualone can be decreased when combined with Clarithromycin.
Methotrimeprazine
Methotrimeprazine may increase the QTc-prolonging activities of Clarithromycin.
Methoxsalen
The metabolism of Methoxsalen can be decreased when combined with Clarithromycin.
Methoxyflurane
The metabolism of Methoxyflurane can be decreased when combined with Clarithromycin.
Methylergonovine
The risk or severity of adverse effects can be increased when Methylergometrine is combined with Clarithromycin.
Methylprednisolone
The serum concentration of Methylprednisolone can be increased when it is combined with Clarithromycin.
Methyltestosterone
The metabolism of Methyltestosterone can be decreased when combined with Clarithromycin.
Methysergide
The risk or severity of adverse effects can be increased when Methysergide is combined with Clarithromycin.
Metoclopramide
Metoclopramide may increase the QTc-prolonging activities of Clarithromycin.
Metronidazole
The metabolism of Metronidazole can be decreased when combined with Clarithromycin.
Mexiletine
The metabolism of Mexiletine can be decreased when combined with Clarithromycin.
Mianserin
The metabolism of Mianserin can be decreased when combined with Clarithromycin.
Mibefradil
The metabolism of Mibefradil can be decreased when combined with Clarithromycin.
Miconazole
The metabolism of Miconazole can be decreased when combined with Clarithromycin.
Midazolam
The serum concentration of Midazolam can be increased when it is combined with Clarithromycin.
Midecamycin
The metabolism of Midecamycin can be decreased when combined with Clarithromycin.
Midostaurin
The metabolism of Midostaurin can be decreased when combined with Clarithromycin.
Mifepristone
Mifepristone may increase the QTc-prolonging activities of Clarithromycin.
Mirabegron
The metabolism of Mirabegron can be decreased when combined with Clarithromycin.
Mirtazapine
The metabolism of Mirtazapine can be decreased when combined with Clarithromycin.
Mitotane
The serum concentration of Clarithromycin can be decreased when it is combined with Mitotane.
Moclobemide
The metabolism of Clarithromycin can be decreased when combined with Moclobemide.
Modafinil
The metabolism of Modafinil can be decreased when combined with Clarithromycin.
Moexipril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Moexipril.
Mometasone
The serum concentration of Mometasone can be increased when it is combined with Clarithromycin.
Montelukast
The metabolism of Montelukast can be decreased when combined with Clarithromycin.
Morphine
The metabolism of Morphine can be decreased when combined with Clarithromycin.
Moxifloxacin
Moxifloxacin may increase the QTc-prolonging activities of Clarithromycin.
Mycophenolate Mofetil
The metabolism of Mycophenolate mofetil can be decreased when combined with Clarithromycin.
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Clarithromycin.
Naloxone
The metabolism of Naloxone can be decreased when combined with Clarithromycin.
Nateglinide
The metabolism of Nateglinide can be decreased when combined with Clarithromycin.
Nefazodone
The metabolism of Clarithromycin can be decreased when combined with Nefazodone.
Nelfinavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Nelfinavir.
Neratinib
The metabolism of Neratinib can be decreased when combined with Clarithromycin.
Netupitant
The serum concentration of Clarithromycin can be increased when it is combined with Netupitant.
Nevirapine
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Nevirapine.
Nicardipine
The metabolism of Nicardipine can be decreased when combined with Clarithromycin.
Nicergoline
The risk or severity of adverse effects can be increased when Nicergoline is combined with Clarithromycin.
Nicotine
The metabolism of Nicotine can be decreased when combined with Clarithromycin.
Nicotine Polacrilex
The metabolism of Nicotine can be decreased when combined with Clarithromycin.
Nifedipine
The metabolism of Nifedipine can be decreased when combined with Clarithromycin.
Nilotinib
The serum concentration of Nilotinib can be increased when it is combined with Clarithromycin.
Nilvadipine
The metabolism of Nilvadipine can be decreased when combined with Clarithromycin.
Nimodipine
The serum concentration of Nimodipine can be increased when it is combined with Clarithromycin.
Nintedanib
The serum concentration of Nintedanib can be increased when it is combined with Clarithromycin.
Nisoldipine
The serum concentration of Nisoldipine can be increased when it is combined with Clarithromycin.
Nitrazepam
The metabolism of Nitrazepam can be decreased when combined with Clarithromycin.
Nitrendipine
The metabolism of Nitrendipine can be decreased when combined with Clarithromycin.
Norethindrone
The metabolism of Norethisterone can be decreased when combined with Clarithromycin.
Norfloxacin
Norfloxacin may increase the QTc-prolonging activities of Clarithromycin.
Norgestrel
The metabolism of Norgestrel can be decreased when combined with Clarithromycin.
Nortriptyline
The metabolism of Nortriptyline can be decreased when combined with Clarithromycin.
O-PHENANTHROLINE
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with 1,10-Phenanthroline.
Octreotide
Octreotide may increase the QTc-prolonging activities of Clarithromycin.
Ofloxacin
Ofloxacin may increase the QTc-prolonging activities of Clarithromycin.
Olanzapine
Olanzapine may increase the QTc-prolonging activities of Clarithromycin.
Olaparib
The serum concentration of Olaparib can be increased when it is combined with Clarithromycin.
Olodaterol
Olodaterol may increase the QTc-prolonging activities of Clarithromycin.
Olopatadine
The metabolism of Olopatadine can be decreased when combined with Clarithromycin.
Omeprazole
The metabolism of Omeprazole can be decreased when combined with Clarithromycin.
Ondansetron
The metabolism of Ondansetron can be decreased when combined with Clarithromycin.
Opium
The metabolism of Opium can be decreased when combined with Clarithromycin.
Orphenadrine
The metabolism of Orphenadrine can be decreased when combined with Clarithromycin.
Osimertinib
The serum concentration of Osimertinib can be increased when it is combined with Clarithromycin.
Ospemifene
The serum concentration of Ospemifene can be increased when it is combined with Clarithromycin.
Ouabain
The serum concentration of Ouabain can be increased when it is combined with Clarithromycin.
Ovine Digoxin Immune Fab
The serum concentration of Digoxin Immune Fab (Ovine) can be increased when it is combined with Clarithromycin.
Oxazepam
The metabolism of Oxazepam can be decreased when combined with Clarithromycin.
Oxybutynin
The serum concentration of Oxybutynin can be increased when it is combined with Clarithromycin.
Oxycodone
The risk or severity of adverse effects can be increased when Clarithromycin is combined with Oxycodone.
Oxymorphone
The metabolism of Oxymorphone can be decreased when combined with Clarithromycin.
Oxytocin
Oxytocin may increase the QTc-prolonging activities of Clarithromycin.
Paclitaxel
The metabolism of Paclitaxel can be decreased when combined with Clarithromycin.
Palbociclib
The serum concentration of Palbociclib can be increased when it is combined with Clarithromycin.
Paliperidone
Clarithromycin may increase the QTc-prolonging activities of Paliperidone.
Palonosetron
The metabolism of Palonosetron can be decreased when combined with Clarithromycin.
Panobinostat
The serum concentration of Panobinostat can be increased when it is combined with Clarithromycin.
Pantoprazole
The metabolism of Pantoprazole can be decreased when combined with Clarithromycin.
Paramethadione
The metabolism of Paramethadione can be decreased when combined with Clarithromycin.
Paramethasone
The metabolism of Paramethasone can be decreased when combined with Clarithromycin.
Parecoxib
The serum concentration of Parecoxib can be increased when it is combined with Clarithromycin.
Paregoric
The metabolism of Morphine can be decreased when combined with Clarithromycin.
Paricalcitol
The serum concentration of Paricalcitol can be increased when it is combined with Clarithromycin.
Paritaprevir
The metabolism of Paritaprevir can be decreased when combined with Clarithromycin.
Paroxetine
Paroxetine may increase the QTc-prolonging activities of Clarithromycin.
Pasireotide
Pasireotide may increase the QTc-prolonging activities of Clarithromycin.
Pazopanib
The serum concentration of Pazopanib can be increased when it is combined with Clarithromycin.
Pentamidine
The metabolism of Pentamidine can be decreased when combined with Clarithromycin.
Pentobarbital
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Pentobarbital.
Perampanel
The metabolism of Perampanel can be decreased when combined with Clarithromycin.
Perflutren
Perflutren may increase the QTc-prolonging activities of Clarithromycin.
Pergolide
The risk or severity of adverse effects can be increased when Pergolide is combined with Clarithromycin.
Perhexiline
The metabolism of Perhexiline can be decreased when combined with Clarithromycin.
Perindopril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Perindopril.
Permethrin
The metabolism of Permethrin can be decreased when combined with Clarithromycin.
Perphenazine
The metabolism of Perphenazine can be decreased when combined with Clarithromycin.
Phenacetin
The metabolism of Phenacetin can be decreased when combined with Clarithromycin.
Phenindione
The serum concentration of Phenindione can be increased when it is combined with Clarithromycin.
Phenobarbital
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenobarbital.
Phenoxybenzamine
The metabolism of Phenoxybenzamine can be decreased when combined with Clarithromycin.
Phenprocoumon
The metabolism of Phenprocoumon can be decreased when combined with Clarithromycin.
Phenytoin
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Phenytoin.
Picosulfuric Acid
The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with Clarithromycin.
Pilocarpine
The metabolism of Pilocarpine can be decreased when combined with Clarithromycin.
Pimecrolimus
The metabolism of Pimecrolimus can be decreased when combined with Clarithromycin.
Pimozide
The risk or severity of ventricular arrhythmias can be increased when Clarithromycin is combined with Pimozide.
Pinacidil
The metabolism of Pinacidil can be decreased when combined with Clarithromycin.
Pioglitazone
The metabolism of Pioglitazone can be decreased when combined with Clarithromycin.
Pipothiazine
The metabolism of Pipotiazine can be decreased when combined with Clarithromycin.
Pitavastatin
The serum concentration of Pitavastatin can be increased when it is combined with Clarithromycin.
Podofilox
The metabolism of Podofilox can be decreased when combined with Clarithromycin.
Pomalidomide
The metabolism of Pomalidomide can be decreased when combined with Clarithromycin.
Ponatinib
The serum concentration of Ponatinib can be increased when it is combined with Clarithromycin.
Posaconazole
The metabolism of Posaconazole can be decreased when combined with Clarithromycin.
Prasterone
The metabolism of Prasterone can be decreased when combined with Clarithromycin.
Prasugrel
The serum concentration of the active metabolites of Prasugrel can be reduced when Prasugrel is used in combination with Clarithromycin resulting in a loss in efficacy.
Pravastatin
The serum concentration of Pravastatin can be increased when it is combined with Clarithromycin.
Prazepam
The metabolism of Prazepam can be decreased when combined with Clarithromycin.
Praziquantel
The metabolism of Praziquantel can be decreased when combined with Clarithromycin.
Prednicarbate
The serum concentration of Prednicarbate can be increased when it is combined with Clarithromycin.
Prednisolone
The serum concentration of Prednisolone can be increased when it is combined with Clarithromycin.
Prednisone
The serum concentration of Prednisone can be increased when it is combined with Clarithromycin.
Pregnenolone
The serum concentration of Pregnenolone can be increased when it is combined with Clarithromycin.
Primaquine
The metabolism of Primaquine can be decreased when combined with Clarithromycin.
Primidone
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Primidone.
Procainamide
Clarithromycin may increase the QTc-prolonging activities of Procainamide.
Prochlorperazine
The metabolism of Prochlorperazine can be decreased when combined with Clarithromycin.
Progesterone
The metabolism of Progesterone can be decreased when combined with Clarithromycin.
Proguanil
The metabolism of Proguanil can be decreased when combined with Clarithromycin.
Promazine
The metabolism of Promazine can be decreased when combined with Clarithromycin.
Promethazine
Promethazine may increase the QTc-prolonging activities of Clarithromycin.
Propafenone
The serum concentration of Propafenone can be increased when it is combined with Clarithromycin.
Propiverine
The metabolism of Propiverine can be decreased when combined with Clarithromycin.
Propofol
The metabolism of Propofol can be decreased when combined with Clarithromycin.
Propoxyphene
The metabolism of Dextropropoxyphene can be decreased when combined with Clarithromycin.
Propranolol
The metabolism of Propranolol can be decreased when combined with Clarithromycin.
Proscillaridin
The serum concentration of Proscillaridin can be increased when it is combined with Clarithromycin.
Protriptyline
Protriptyline may increase the QTc-prolonging activities of Clarithromycin.
Pyrazinamide
The metabolism of Pyrazinamide can be decreased when combined with Clarithromycin.
Quazepam
The metabolism of Quazepam can be decreased when combined with Clarithromycin.
Quetiapine
The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.
Quetiapine fumarate
The serum concentration of Quetiapine can be increased when it is combined with Clarithromycin.
Quinacrine
The metabolism of Quinacrine can be decreased when combined with Clarithromycin.
Quinapril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Quinapril.
Quinidine
Clarithromycin may increase the QTc-prolonging activities of Quinidine.
Quinine
The serum concentration of Quinine can be increased when it is combined with Clarithromycin.
Rabeprazole
The metabolism of Rabeprazole can be decreased when combined with Clarithromycin.
Racecadotril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Racecadotril.
Raloxifene
The metabolism of Raloxifene can be decreased when combined with Clarithromycin.
Ramelteon
The serum concentration of Ramelteon can be increased when it is combined with Clarithromycin.
Ramipril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Ramipril.
Ranolazine
The serum concentration of Ranolazine can be increased when it is combined with Clarithromycin.
Reboxetine
The metabolism of Reboxetine can be decreased when combined with Clarithromycin.
Regorafenib
The serum concentration of Regorafenib can be increased when it is combined with Clarithromycin.
Repaglinide
The serum concentration of Repaglinide can be increased when it is combined with Clarithromycin.
Retapamulin
The serum concentration of Retapamulin can be increased when it is combined with Clarithromycin.
Ribociclib
The risk or severity of QTc prolongation can be increased when Ribociclib is combined with Clarithromycin.
Rifabutin
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifabutin.
Rifampin
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifampicin.
Rifapentine
The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Rifapentine.
Rifaximin
The serum concentration of Rifaximin can be increased when it is combined with Clarithromycin.
Rilpivirine
The serum concentration of Rilpivirine can be decreased when it is combined with Clarithromycin.
Rimexolone
The serum concentration of Rimexolone can be increased when it is combined with Clarithromycin.
Riociguat
The metabolism of Riociguat can be decreased when combined with Clarithromycin.
Risperidone
The metabolism of Risperidone can be decreased when combined with Clarithromycin.
Ritonavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Ritonavir.
Rivaroxaban
The serum concentration of Rivaroxaban can be increased when it is combined with Clarithromycin.
Rofecoxib
The metabolism of Rofecoxib can be decreased when combined with Clarithromycin.
Rolapitant
The metabolism of Rolapitant can be decreased when combined with Clarithromycin.
Romidepsin
The serum concentration of Romidepsin can be increased when it is combined with Clarithromycin.
Ropinirole
The metabolism of Ropinirole can be decreased when combined with Clarithromycin.
Ropivacaine
The metabolism of Ropivacaine can be decreased when combined with Clarithromycin.
Rosuvastatin
The serum concentration of Rosuvastatin can be increased when it is combined with Clarithromycin.
Rotigotine
The metabolism of Rotigotine can be decreased when combined with Clarithromycin.
Roxithromycin
The metabolism of Roxithromycin can be decreased when combined with Clarithromycin.
Rucaparib
The metabolism of Rucaparib can be decreased when combined with Clarithromycin.
Ruxolitinib
The serum concentration of Ruxolitinib can be increased when it is combined with Clarithromycin.
Safinamide
The metabolism of Safinamide can be decreased when combined with Clarithromycin.
Salmeterol
The serum concentration of Salmeterol can be increased when it is combined with Clarithromycin.
Saquinavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Saquinavir.
Saquinavir Mesylate
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Saquinavir.
Sarilumab
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Sarilumab.
Saxagliptin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Saxagliptin.
Saxagliptin Anhydrous
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Saxagliptin.
Selegiline
The metabolism of Selegiline can be decreased when combined with Clarithromycin.
Selexipag
The metabolism of Selexipag can be decreased when combined with Clarithromycin.
Sertindole
The metabolism of Sertindole can be decreased when combined with Clarithromycin.
Sertraline
The metabolism of Sertraline can be decreased when combined with Clarithromycin.
Sevoflurane
The metabolism of Sevoflurane can be decreased when combined with Clarithromycin.
Sibutramine
The metabolism of Sibutramine can be decreased when combined with Clarithromycin.
Sildenafil
The serum concentration of Sildenafil can be increased when it is combined with Clarithromycin.
Silodosin
The serum concentration of Silodosin can be increased when it is combined with Clarithromycin.
Siltuximab
The serum concentration of Clarithromycin can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Simeprevir can be increased when it is combined with Clarithromycin.
Simvastatin
The serum concentration of Simvastatin can be increased when it is combined with Clarithromycin.
Sirolimus
The metabolism of Sirolimus can be decreased when combined with Clarithromycin.
Sitagliptin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Sitagliptin.
Sitagliptin Phosphate
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Sitagliptin.
Solifenacin
The metabolism of Solifenacin can be decreased when combined with Clarithromycin.
Sonidegib
The serum concentration of Sonidegib can be increased when it is combined with Clarithromycin.
Sorafenib
The serum concentration of Sorafenib can be increased when it is combined with Clarithromycin.
Sotalol
Clarithromycin may increase the QTc-prolonging activities of Sotalol.
Spiramycin
The metabolism of Spiramycin can be decreased when combined with Clarithromycin.
Spirapril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Spirapril.
ST. JOHN'S WORT EXTRACT
The serum concentration of Clarithromycin can be decreased when it is combined with St. John's Wort.
Sufentanil
The metabolism of Sufentanil can be decreased when combined with Clarithromycin.
Sulfadiazine
The metabolism of Sulfadiazine can be decreased when combined with Clarithromycin.
Sulfamethoxazole
The metabolism of Sulfamethoxazole can be decreased when combined with Clarithromycin.
Sulfinpyrazone
The metabolism of Sulfinpyrazone can be decreased when combined with Clarithromycin.
Sulfisoxazole
Sulfisoxazole may increase the QTc-prolonging activities of Clarithromycin.
Sunitinib
The metabolism of Sunitinib can be decreased when combined with Clarithromycin.
Suvorexant
The serum concentration of Suvorexant can be increased when it is combined with Clarithromycin.
synthetic conjugated estrogens, A
The metabolism of Synthetic Conjugated Estrogens, A can be decreased when combined with Clarithromycin.
synthetic conjugated estrogens, B
The metabolism of Synthetic Conjugated Estrogens, B can be decreased when combined with Clarithromycin.
Tacrolimus
The serum concentration of Tacrolimus can be increased when it is combined with Clarithromycin.
Tadalafil
The serum concentration of Tadalafil can be increased when it is combined with Clarithromycin.
Tamoxifen
The metabolism of Tamoxifen can be decreased when combined with Clarithromycin.
Tamsulosin
The serum concentration of Tamsulosin can be increased when it is combined with Clarithromycin.
Tasimelteon
The serum concentration of Tasimelteon can be increased when it is combined with Clarithromycin.
Telaprevir
The serum concentration of Telaprevir can be increased when it is combined with Clarithromycin.
Telavancin
Clarithromycin may increase the QTc-prolonging activities of Telavancin.
Telithromycin
The metabolism of Clarithromycin can be decreased when combined with Telithromycin.
Temazepam
The metabolism of Temazepam can be decreased when combined with Clarithromycin.
Temsirolimus
The risk or severity of adverse effects can be increased when Clarithromycin is combined with Temsirolimus.
Teniposide
The metabolism of Teniposide can be decreased when combined with Clarithromycin.
Terbinafine
The metabolism of Terbinafine can be decreased when combined with Clarithromycin.
Terbutaline
Terbutaline may increase the QTc-prolonging activities of Clarithromycin.
Terbutaline Sulfate
Terbutaline may increase the QTc-prolonging activities of Clarithromycin.
Terfenadine
The serum concentration of Terfenadine can be increased when it is combined with Clarithromycin.
Testosterone
The metabolism of Testosterone can be decreased when combined with Clarithromycin.
Testosterone Cypionate
The metabolism of Testosterone cypionate can be decreased when combined with Clarithromycin.
Testosterone Enanthate
The metabolism of Testosterone enanthate can be decreased when combined with Clarithromycin.
Testosterone Propionate
The metabolism of Testosterone propionate can be decreased when combined with Clarithromycin.
Testosterone Undecanoate
The metabolism of Testosterone undecanoate can be decreased when combined with Clarithromycin.
Tetrabenazine
Clarithromycin may increase the QTc-prolonging activities of Tetrabenazine.
Tetracycline
The metabolism of Tetracycline can be decreased when combined with Clarithromycin.
Tetrahydrocannabinol
The serum concentration of Dronabinol can be increased when it is combined with Clarithromycin.
Tezacaftor
The serum concentration of Tezacaftor can be increased when it is combined with Clarithromycin.
Theophylline
The metabolism of Theophylline can be decreased when combined with Clarithromycin.
Theophylline anhydrous
The metabolism of Theophylline can be decreased when combined with Clarithromycin.
Thioridazine
Clarithromycin may increase the QTc-prolonging activities of Thioridazine.
Thiotepa
The metabolism of Thiotepa can be decreased when combined with Clarithromycin.
Thiothixene
Thiothixene may increase the QTc-prolonging activities of Clarithromycin.
Tiagabine
The metabolism of Tiagabine can be decreased when combined with Clarithromycin.
Ticagrelor
The serum concentration of the active metabolites of Ticagrelor can be reduced when Ticagrelor is used in combination with Clarithromycin resulting in a loss in efficacy.
Ticlopidine
The metabolism of Ticlopidine can be decreased when combined with Clarithromycin.
Tinidazole
The metabolism of Tinidazole can be decreased when combined with Clarithromycin.
Tiotropium
The metabolism of Tiotropium can be decreased when combined with Clarithromycin.
Tipranavir
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Tipranavir.
Tixocortol
The serum concentration of Tixocortol can be increased when it is combined with Clarithromycin.
Tizanidine
The serum concentration of Tizanidine can be increased when it is combined with Clarithromycin.
Tocilizumab
The serum concentration of Clarithromycin can be decreased when it is combined with Tocilizumab.
Tocopherol
The metabolism of Tocopherol can be decreased when combined with Clarithromycin.
Tocopherol Acetate
The metabolism of alpha-Tocopherol acetate can be decreased when combined with Clarithromycin.
Tocophersolan
The metabolism of Tocofersolan can be decreased when combined with Clarithromycin.
Tofacitinib
The serum concentration of Tofacitinib can be increased when it is combined with Clarithromycin.
Tolterodine
The serum concentration of Tolterodine can be increased when it is combined with Clarithromycin.
Tolvaptan
The serum concentration of Tolvaptan can be increased when it is combined with Clarithromycin.
Topiramate
The metabolism of Clarithromycin can be decreased when combined with Topiramate.
Topotecan
The serum concentration of Topotecan can be increased when it is combined with Clarithromycin.
Toremifene
The risk or severity of adverse effects can be increased when Clarithromycin is combined with Toremifene.
Trabectedin
The serum concentration of Trabectedin can be increased when it is combined with Clarithromycin.
Tramadol
The serum concentration of Tramadol can be increased when it is combined with Clarithromycin.
Trandolapril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Trandolapril.
Tranylcypromine
The metabolism of Clarithromycin can be decreased when combined with Tranylcypromine.
Trazodone
The metabolism of Trazodone can be decreased when combined with Clarithromycin.
Treprostinil
Treprostinil may increase the QTc-prolonging activities of Clarithromycin.
Tretinoin
The metabolism of Tretinoin can be decreased when combined with Clarithromycin.
Triamcinolone
The metabolism of Triamcinolone can be decreased when combined with Clarithromycin.
Triazolam
The serum concentration of Triazolam can be increased when it is combined with Clarithromycin.
Trimethadione
The metabolism of Trimethadione can be decreased when combined with Clarithromycin.
Trimethoprim
The metabolism of Trimethoprim can be decreased when combined with Clarithromycin.
Trimipramine
The metabolism of Trimipramine can be decreased when combined with Clarithromycin.
Triptorelin
Triptorelin may increase the QTc-prolonging activities of Clarithromycin.
Troglitazone
The metabolism of Troglitazone can be decreased when combined with Clarithromycin.
Troleandomycin
The metabolism of Troleandomycin can be decreased when combined with Clarithromycin.
Ulipristal
The serum concentration of Ulipristal can be increased when it is combined with Clarithromycin.
Valbenazine
The metabolism of Valbenazine can be decreased when combined with Clarithromycin.
Valdecoxib
The metabolism of Valdecoxib can be decreased when combined with Clarithromycin.
Vandetanib
Clarithromycin may increase the QTc-prolonging activities of Vandetanib.
Vardenafil
The serum concentration of Vardenafil can be increased when it is combined with Clarithromycin.
Velpatasvir
The metabolism of Velpatasvir can be decreased when combined with Clarithromycin.
Vemurafenib
The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Clarithromycin.
Venetoclax
The metabolism of Venetoclax can be decreased when combined with Clarithromycin.
Venlafaxine
The metabolism of Venlafaxine can be decreased when combined with Clarithromycin.
Verapamil
The metabolism of Verapamil can be decreased when combined with Clarithromycin.
Vilanterol
The metabolism of Vilanterol can be decreased when combined with Clarithromycin.
Vilazodone
The serum concentration of Vilazodone can be increased when it is combined with Clarithromycin.
Vildagliptin
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Vildagliptin.
Vinblastine
The metabolism of Vinblastine can be decreased when combined with Clarithromycin.
Vincamine
The serum concentration of Vincamine can be increased when it is combined with Clarithromycin.
Vincristine
The serum concentration of Vincristine can be increased when it is combined with Clarithromycin.
Vindesine
The serum concentration of Vindesine can be increased when it is combined with Clarithromycin.
Vinorelbine
The metabolism of Vinorelbine can be decreased when combined with Clarithromycin.
Vismodegib
The metabolism of Vismodegib can be decreased when combined with Clarithromycin.
vitamine E acetate
The metabolism of alpha-Tocopherol acetate can be decreased when combined with Clarithromycin.
Vorapaxar
The serum concentration of Vorapaxar can be increased when it is combined with Clarithromycin.
Voriconazole
The metabolism of Clarithromycin can be decreased when combined with Voriconazole.
Vorinostat
Vorinostat may increase the QTc-prolonging activities of Clarithromycin.
Vortioxetine
The metabolism of Vortioxetine can be decreased when combined with Clarithromycin.
Voxilaprevir
The metabolism of Voxilaprevir can be decreased when combined with Clarithromycin.
Warfarin
The metabolism of Warfarin can be decreased when combined with Clarithromycin.
Yohimbine
The metabolism of Yohimbine can be decreased when combined with Clarithromycin.
Zafirlukast
The metabolism of Zafirlukast can be decreased when combined with Clarithromycin.
Zalcitabine
The metabolism of Zalcitabine can be decreased when combined with Clarithromycin.
Zaleplon
The metabolism of Zaleplon can be decreased when combined with Clarithromycin.
Zidovudine
Clarithromycin may increase the myelosuppressive activities of Zidovudine.
Zileuton
The metabolism of Zileuton can be decreased when combined with Clarithromycin.
Ziprasidone
Clarithromycin may increase the QTc-prolonging activities of Ziprasidone.
Zofenopril
The therapeutic efficacy of Clarithromycin can be decreased when used in combination with Zofenopril.
Zolpidem
The metabolism of Zolpidem can be decreased when combined with Clarithromycin.
Zomepirac
The metabolism of Zomepirac can be decreased when combined with Clarithromycin.
Zonisamide
The metabolism of Zonisamide can be decreased when combined with Clarithromycin.
Zopiclone
The serum concentration of Zopiclone can be increased when it is combined with Clarithromycin.
Zotepine
The metabolism of Zotepine can be decreased when combined with Clarithromycin.
Zuclopenthixol
The serum concentration of Zuclopenthixol can be increased when it is combined with Clarithromycin.
